Expertise in
3
conditions

Dr. Kupper A. Wintergerst

Pediatric Endocrinology
Norton Children's Sleep Medicine-Novak Center
411 E Chestnut St, 
Louisville, KY 
Accepting New Patients
Referral may be required
Before you request
Expertise in
3
conditions
Norton Children's Sleep Medicine-Novak Center
411 E Chestnut St, 
Louisville, KY 

Overview

Kupper Wintergerst is a Pediatric Endocrinologist practicing medicine in Louisville, Kentucky.

Dr. Wintergerst is highly rated in 3 conditions, according to our data. His clinical expertise encompasses Type 1 Diabetes (T1D), Neonatal Hypothyroidism, Congenital Hypothyroidism, and Ovarian Overproduction of Androgens.

He is actively involved in clinical research, co-authoring 59 peer reviewed articles and participating in 4 clinical trials. Dr. Wintergerst is currently accepting new patients.

Specialties

Pediatric Endocrinology

Licenses

Pediatric Endocrinology in KY

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
CareSource
  • HMO
Cigna
  • EPO
  • HMO
  • PPO
Horizon Healthcare
  • EPO
  • POS
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
MDwise
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
TeamCare
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 9 Less Insurance Carriers -

Locations

Norton Children's Sleep Medicine-Novak Center
411 E Chestnut St, Louisville, KY 40202

Additional Areas of Focus

Dr. Wintergerst has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Hypoparathyroidism
Non-Alcoholic Fatty Liver Disease
Nonalcoholic Steatohepatitis (NASH)
Pediatric Growth Hormone Deficiency

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

A Multicenter, 24-Month, Randomized, Open-Label, Active Control, Parallel Arm, Phase 2 Study of Daily Oral LUM-201 in Naïve-to-Treatment, Prepubertal Children With Idiopathic Growth Hormone Deficiency (GHD)
A Multicenter, 24-Month, Randomized, Open-Label, Active Control, Parallel Arm, Phase 2 Study of Daily Oral LUM-201 in Naïve-to-Treatment, Prepubertal Children With Idiopathic Growth Hormone Deficiency (GHD)
Enrollment Status: Completed
Publish Date: June 17, 2026
Intervention Type: Drug
Study Drugs: LUM-201, rhGH Norditropin® pen
Study Phase: Phase 2
INHALE-1: A 26-week Primary Treatment Phase, With 26-week Extension, Open-label, Randomized Clinical Trial Evaluating the Efficacy and Safety of Afrezza® Versus Rapid-acting Insulin Analog Injections, Both in Combination With a Basal Insulin, in Pediatric Subjects With Type 1 or Type 2 Diabetes Mellitus
INHALE-1: A 26-week Primary Treatment Phase, With 26-week Extension, Open-label, Randomized Clinical Trial Evaluating the Efficacy and Safety of Afrezza® Versus Rapid-acting Insulin Analog Injections, Both in Combination With a Basal Insulin, in Pediatric Subjects With Type 1 or Type 2 Diabetes Mellitus
Enrollment Status: Completed
Publish Date: May 06, 2025
Intervention Type: Biological
Study Drugs: Afrezza, Rapid-acting Insulin Analog, Basal Insulin
Study Phase: Phase 3
Hydroxychloroquine for Prevention of Abnormal Glucose Tolerance and Diabetes in Individuals At-risk for Type 1 Diabetes Mellitus (T1D)
Hydroxychloroquine for Prevention of Abnormal Glucose Tolerance and Diabetes in Individuals At-risk for Type 1 Diabetes Mellitus (T1D)
Enrollment Status: Terminated
Publish Date: April 09, 2024
Intervention Type: Drug
Study Drug: Hydroxychloroquine
Study Phase: Phase 2
The Impact of Mobile Technology on Clinical Outcomes in Children and Adolescents With Type 1 Diabetes
The Impact of Mobile Technology on Clinical Outcomes in Children and Adolescents With Type 1 Diabetes
Enrollment Status: Withdrawn
Publish Date: December 17, 2018
Intervention Type: Other
Study Phase: Not Applicable
View 3 Less Clinical Trials

59 Total Publications

Human FGF1ΔHBS Gene Therapy as Treatment for Metabolic Dysfunction-Associated Steatohepatitis in ApoE-KO Mice.
Human FGF1ΔHBS Gene Therapy as Treatment for Metabolic Dysfunction-Associated Steatohepatitis in ApoE-KO Mice.
Journal: Cells
Published: December 30, 2025
Similar Doctors
Expertise in
8
conditions
Dr. Susan Raghavan
Pediatric Endocrinology
Expertise in
8
conditions
Dr. Susan Raghavan
Pediatric Endocrinology
Referral may be required
Before you request

Susan Raghavan MD

9720 Park Plaza Ave Unit 202, 
Louisville, KY 
 (9.9 miles away)
502-895-9155
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Susan Raghavan is a Pediatric Endocrinologist practicing medicine in Louisville, Kentucky. Dr. Raghavan is highly rated in 8 conditions, according to our data. Her clinical expertise encompasses Precocious Puberty, Pediatric Growth Hormone Deficiency, Growth Hormone Deficiency (GHD), and Sheehan Syndrome. Dr. Raghavan is currently accepting new patients.

Expertise in
1
conditions
Dr. Catalina Salcedo
Pediatric Endocrinology
Expertise in
1
conditions
Dr. Catalina Salcedo
Pediatric Endocrinology
Referral may be required
Before you request

Norton Children's Sleep Medicine-Novak Center

411 E Chestnut St, 
Louisville, KY 
 (0.1 miles away)
502-588-3400
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Catalina Salcedo is a Pediatric Endocrinologist practicing medicine in Louisville, Kentucky. Dr. Salcedo is highly rated in 1 condition, according to our data. Her clinical expertise encompasses Type 1 Diabetes (T1D), Type A Insulin Resistance Syndrome, Acanthosis Nigricans, and Turner Syndrome. Dr. Salcedo is currently accepting new patients.

Expertise in
1
conditions
Dr. Sara E. Watson
Pediatric Endocrinology
Expertise in
1
conditions
Dr. Sara E. Watson
Pediatric Endocrinology
Referral may be required
Before you request

Norton Children's Sleep Medicine-Novak Center

411 E Chestnut St, 
Louisville, KY 
 (0.1 miles away)
502-588-3400
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Sara Watson is a Pediatric Endocrinologist practicing medicine in Louisville, Kentucky. Dr. Watson is highly rated in 1 condition, according to our data. Her clinical expertise encompasses Type 1 Diabetes (T1D), Type 2 Diabetes (T2D), Low Blood Sugar, and Familial Short Stature (FSS). Dr. Watson is currently accepting new patients.

Frequently Asked Questions about Dr. Kupper A. Wintergerst

How do I make an appointment with Dr. Kupper A. Wintergerst?

You can book an appointment with Dr. Kupper A. Wintergerst by calling their office at 502-588-3400. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Kupper A. Wintergerst a top-rated expert for Type 1 Diabetes (T1D)?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Kupper A. Wintergerst is classified as an Advanced expert for Type 1 Diabetes (T1D), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Kupper A. Wintergerst specialize in?

While Dr. Kupper A. Wintergerst is a Pediatric Endocrinology, they have specific expertise in Type 1 Diabetes (T1D), Neonatal Hypothyroidism, and Congenital Hypothyroidism. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Pediatric Endocrinology.

Does Dr. Kupper A. Wintergerst participate in research or clinical trials?

Yes. Dr. Kupper A. Wintergerst has published 59 articles and abstracts on conditions like Type 1 Diabetes (T1D). You can view a list of Dr. Kupper A. Wintergerst's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Kupper A. Wintergerst accept my insurance?

Dr. Kupper A. Wintergerst accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 502-588-3400 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Wintergerst's expertise for a condition
ConditionClose
      View All 15 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile